Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Brima Musa"'
Autor:
Ana Torres, Brima Musa Younis, Mohammed Alamin, Samuel Tesema, Lorena Bernardo, Jose Carlos Solana, Javier Moreno, Alaa-aldeen Mustafa, Fabiana Alves, Ahmed Mudawi Musa, Eugenia Carrillo
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 3, Pp 1167-1179 (2024)
Abstract Background The host cellular immune response associated with two treatments for post-kala-azar dermal leishmaniasis (PKDL) - paromomycin plus miltefosine (Arm 1), and liposomal amphotericin B plus miltefosine (Arm 2) - was examined in Sudane
Externí odkaz:
https://doaj.org/article/dae4e910c4ba4894800cc7f1106cc8ea
Autor:
Younis, Brima Musa1 (AUTHOR), Mudawi Musa, Ahmed1 (AUTHOR), Monnerat, Séverine2 (AUTHOR), Abdelrahim Saeed, Mohammed1 (AUTHOR), Awad Gasim Khalil, Eltahir1 (AUTHOR), Elbashir Ahmed, Anas1 (AUTHOR), Ahmed Ali, Mujahid1 (AUTHOR), Noureldin, Ali1 (AUTHOR), Muthoni Ouattara, Gina3 (AUTHOR), Nyakaya, Godfrey M.3 (AUTHOR), Teshome, Samuel3 (AUTHOR), Omollo, Truphosa3 (AUTHOR), Ochieng, Michael3 (AUTHOR), Egondi, Thaddaeus3 (AUTHOR), Mmbone, Mildred3 (AUTHOR), Chu, Wan-Yu4 (AUTHOR), Dorlo, Thomas P. C.5 (AUTHOR), Zijlstra, Eduard E.2 (AUTHOR), Wasunna, Monique3 (AUTHOR), Alvar, Jorge2 (AUTHOR)
Publikováno v:
PLoS Neglected Tropical Diseases. 11/21/2023, Vol. 17 Issue 11, p1-20. 20p.
Autor:
Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P C Dorlo, Eduard E Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 11, p e0011780 (2023)
BackgroundTreatment for post-kala-azar dermal leishmaniasis (PKDL) in Sudan is currently recommended only for patients with persistent or severe disease, mainly because of the limitations of current therapies, namely toxicity and long hospitalization
Externí odkaz:
https://doaj.org/article/8e80fbd2c0f14737b661e76f2ce1ecf5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ahmed M, Musa, Jane, Mbui, Rezika, Mohammed, Joseph, Olobo, Koert, Ritmeijer, Gabriel, Alcoba, Gina, Muthoni Ouattara, Thaddaeus, Egondi, Prossy, Nakanwagi, Truphosa, Omollo, Monique, Wasunna, Luka, Verrest, Thomas P C, Dorlo, Brima, Musa Younis, Ali, Nour, Elmukashfi, Taha Ahmed Elmukashfi, Ahmed, Ismail Omer Haroun, Eltahir A G, Khalil, Simon, Njenga, Helina, Fikre, Tigist, Mekonnen, Dagnew, Mersha, Kasaye, Sisay, Patrick, Sagaki, Jorge, Alvar, Alexandra, Solomos, Fabiana, Alves
Publikováno v:
Clinical Infectious Diseases. 76:e1177-e1185
Background This study aimed to determine whether paromomycin plus miltefosine (PM/MF) is noninferior to sodium stibogluconate plus paromomycin (SSG/PM) for treatment of primary visceral leishmaniasis in eastern Africa. Methods An open-label, phase 3,
Autor:
Musa, Ahmed M, Mbui, Jane, Mohammed, Rezika, Olobo, Joseph, Ritmeijer, Koert, Alcoba, Gabriel, Ouattara, Gina Muthoni, Egondi, Thaddaeus, Nakanwagi, Prossy, Omollo, Truphosa, Wasunna, Monique, Verrest, Luka, Dorlo, Thomas P C, Younis, Brima Musa, Nour, Ali, Elmukashfi, Elmukashfi Taha Ahmed, Haroun, Ahmed Ismail Omer, Khalil, Eltahir A G, Njenga, Simon, Fikre, Helina
Publikováno v:
Clinical Infectious Diseases; 2/1/2023, Vol. 76 Issue 3, pe1177-e1185, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Monique Wasunna, Simon Njenga, Manica Balasegaram, Neal Alexander, Raymond Omollo, Tansy Edwards, Thomas P C Dorlo, Brima Musa, Mohammed Hassan Sharaf Ali, Mohammed Yasein Elamin, George Kirigi, Rashid Juma, Anke E Kip, Gerard J Schoone, Asrat Hailu, Joseph Olobo, Sally Ellis, Robert Kimutai, Susan Wells, Eltahir Awad Gasim Khalil, Nathalie Strub Wourgaft, Fabiana Alves, Ahmed Musa
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 10, Iss 9, p e0004880 (2016)
BACKGROUND:SSG&PM over 17 days is recommended as first line treatment for visceral leishmaniasis in eastern Africa, but is painful and requires hospitalization. Combination regimens including AmBisome and miltefosine are safe and effective in India,
Externí odkaz:
https://doaj.org/article/8f00c7ff8e114d8499c8306afaf2b491
Autor:
Shahd Mohamed Mustafa Abbas, Walla Saeed Eltahir Saeed, Osama Mohamed Musa, Mugtaba Elsamani Ahmed, Maria Mohamed H Satti, Brima Musa Younis, Ahmed Mudawi Musa, Eltahir Awad Gasim Khalil
Publikováno v:
Journal of Human Virology & Retrovirology. 8:1-5
Background: Hepatitis B virus (HBV) infection is an immune liver disease affecting millions worldwide. Despite availability of an efficacious vaccine, elimination of HBV infections is aloft. This study aimed to identify the immune-pathological phases
Autor:
Eltahir A G Khalil, Brima Musa, Ahmed Mudawi Mudawi, M. E. E. Elfaki, Elsamani Elmotwafig Mohamed Elsammani
Publikováno v:
Advances in Infectious Diseases. 10:235-242
L. donovani infections (visceral and post kala-azar dermal leishmaniases) are characterized by infection-induced reversible immune suppression. Autoimmunity is a well-documented phenomenon among patients with primary immune deficiencies. This study a